159 related articles for article (PubMed ID: 12048739)
1. Beta blocker use in acute myocardial infarction in West Virginia.
Schade CP; Brehm JG; Stephens MK; Rezek G
W V Med J; 2002; 98(2):56-60. PubMed ID: 12048739
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the effect on patient outcomes of appropriate and inappropriate use of beta-blockers as secondary prevention after myocardial infarction in a medicaid population.
Fernandes AW; Madhavan SS; Amonkar MM
Clin Ther; 2005 May; 27(5):630-45. PubMed ID: 15978313
[TBL] [Abstract][Full Text] [Related]
3. Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction.
Miller CD; Roe MT; Mulgund J; Hoekstra JW; Santos R; Pollack CV; Ohman EM; Gibler WB; Peterson ED
Am J Med; 2007 Aug; 120(8):685-92. PubMed ID: 17679127
[TBL] [Abstract][Full Text] [Related]
4. Prescribing of beta-blockers after myocardial infarction: a preliminary study of physician motivations and barriers.
Kavookjian J; Mamidi S
Clin Ther; 2008; 30 Pt 2():2241-9. PubMed ID: 19281918
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of inappropriate prescribing of beta-blockers after an acute myocardial infarction in a Medicaid population.
Fernandes AW; Madhavan SS; Amonkar MM; Bell D; Islam SS; Scott VG
Ann Pharmacother; 2005 Sep; 39(9):1416-22. PubMed ID: 15972326
[TBL] [Abstract][Full Text] [Related]
6. Changes in rates of beta-blocker use between 1994 and 1997 among elderly survivors of acute myocardial infarction.
Heller DA; Ahern FM; Kozak M
Am Heart J; 2000 Oct; 140(4):663-71. PubMed ID: 11011343
[TBL] [Abstract][Full Text] [Related]
7. Cardiologists' practices compared with practice guidelines: use of beta-blockade after acute myocardial infarction.
Brand DA; Newcomer LN; Freiburger A; Tian H
J Am Coll Cardiol; 1995 Nov; 26(6):1432-6. PubMed ID: 7594066
[TBL] [Abstract][Full Text] [Related]
8. Association between functional status and use and effectiveness of beta-blocker prophylaxis in elderly survivors of acute myocardial infarction.
Vitagliano G; Curtis JP; Concato J; Feinstein AR; Radford MJ; Krumholz HM
J Am Geriatr Soc; 2004 Apr; 52(4):495-501. PubMed ID: 15066062
[TBL] [Abstract][Full Text] [Related]
9. Beta-blocker use in patients with acute myocardial infarction treated by hospitalists.
Dall L; Simmons T; Peterson S; Herndon B
Manag Care Interface; 2000 May; 13(5):61-3, 69. PubMed ID: 11067397
[TBL] [Abstract][Full Text] [Related]
10. Impact of an educational intervention for secondary prevention of myocardial infarction on Medicaid drug use and cost.
Zuckerman IH; Weiss SR; McNally D; Layne B; Mullins CD; Wang J
Am J Manag Care; 2004 Jul; 10(7 Pt 2):493-500. PubMed ID: 15298236
[TBL] [Abstract][Full Text] [Related]
11. Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence.
Simpson E; Beck C; Richard H; Eisenberg MJ; Pilote L
Am Heart J; 2003 Mar; 145(3):438-44. PubMed ID: 12660666
[TBL] [Abstract][Full Text] [Related]
12. Physician characteristics and the initiation of beta-adrenergic blocking agent therapy after acute myocardial infarction in a managed care population.
Fehrenbach SN; Budnitz DS; Gazmararian JA; Krumholz HM
Am J Manag Care; 2001 Jul; 7(7):717-23. PubMed ID: 11464429
[TBL] [Abstract][Full Text] [Related]
13. Communitywide trends in the use and outcomes associated with beta-blockers in patients with acute myocardial infarction: the Worcester Heart Attack Study.
Silvet H; Spencer F; Yarzebski J; Lessard D; Gore JM; Goldberg RJ
Arch Intern Med; 2003 Oct; 163(18):2175-83. PubMed ID: 14557215
[TBL] [Abstract][Full Text] [Related]
14. Parabolas of medication use and discontinuation after myocardial infarction--are we closing the treatment gap?
Hudson M; Richard H; Pilote L
Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):773-85. PubMed ID: 17486661
[TBL] [Abstract][Full Text] [Related]
15. Lack of physician concordance with guidelines on the perioperative use of beta-blockers.
Siddiqui AK; Ahmed S; Delbeau H; Conner D; Mattana J
Arch Intern Med; 2004 Mar; 164(6):664-7. PubMed ID: 15037496
[TBL] [Abstract][Full Text] [Related]
16. Use of beta-blockers and aspirin after myocardial infarction by patient renal function in the Department of Defense health care system.
Abbott KC; Bohen EM; Yuan CM; Yeo FE; Sawyers ES; Perkins RM; Lentine KL; Oliver DK; Galey J; Sebastianelli ME; Scally JP; Taylor AJ; Boal TR
Am J Kidney Dis; 2006 Apr; 47(4):593-603. PubMed ID: 16564937
[TBL] [Abstract][Full Text] [Related]
17. Patterns of practice analysis for acute myocardial infarction.
Tsuyuki RT; Gill S; Hilton JD
Can J Cardiol; 1994 Nov; 10(9):891-6. PubMed ID: 7954024
[TBL] [Abstract][Full Text] [Related]
18. WVMI provides follow-up on beta blocker use.
Schade CP
W V Med J; 2002; 98(5):183. PubMed ID: 12440164
[No Abstract] [Full Text] [Related]
19. Impact of organizational infrastructure on beta-blocker and aspirin therapy for acute myocardial infarction.
Ellerbeck EF; Bhimaraj A; Hall S
Am Heart J; 2006 Sep; 152(3):579-84. PubMed ID: 16923434
[TBL] [Abstract][Full Text] [Related]
20. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).
Piccini JP; Hranitzky PM; Kilaru R; Rouleau JL; White HD; Aylward PE; Van de Werf F; Solomon SD; Califf RM; Velazquez EJ
Am J Cardiol; 2008 Dec; 102(11):1427-32. PubMed ID: 19026290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
